Literature DB >> 33407460

IL-17A polymorphism (rs2275913) and levels are associated with preeclampsia pathogenesis in Chinese patients.

Xiao Lang1,2, Wei Liu1,2, Yanyan Hou1,2, Wenxia Zhao3, Xingyu Yang1,4, Lan Chen1,2, Qi Yan3, Weiwei Cheng5,6.   

Abstract

BACKGROUND: Preeclampsia (PE) is a pregnancy-related condition that affects both the infant and the mother. Although the role of various inflammatory molecules in PE has been demonstrated, the importance of pro-inflammatory molecules such as IL-17A, IL-23 is not well understood. In the present investigation, a potential association of common genetic variants in the IL-17A and IL-23A genes with PE was investigated.
METHODS: 115 PE clinically diagnosed patients who registered to the International Peace Maternity and Child Health Hospital were enrolled in this research. One hundred two pregnant women and 147 healthy Chinese women were also included. ELISA was used to measure IL-17A and IL-23 serum levels in all enrolled subjects. Common genetic polymorphisms in IL-17A (rs 2,275,913, rs1974226, and rs1974226), IL-23A (rs11171806), and IL-12B (rs3212227) were genotyped using the PCR-RFLP or TaqMan probe-based method.
RESULTS: Elevated serum IL-17A levels were found in PE patients compared to pregnant (P < 0.0001) and healthy women (P < 0.0001). However, IL-23 levels were comparable across various clinical groups. In addition, heterozygous (GA) and minor allele (A) for IL-17A (rs2275913) and IL-23A (rs11171806) were more prevalent in PE patients compared to pregnant women indicating an important role in the predisposition to PE growth. Interestingly, IL-17A (r 2,275,913) mutants were associated with elevated IL-17A levels relative to wild type (GG).
CONCLUSIONS: IL-17A (rs2275913) variants are associated with higher serum levels of cytokine, and predisposed PE development.

Entities:  

Keywords:  Gene polymorphism; IL-17A; IL-23A; Preeclampsia; Serum levels

Mesh:

Substances:

Year:  2021        PMID: 33407460      PMCID: PMC7789345          DOI: 10.1186/s12920-020-00840-8

Source DB:  PubMed          Journal:  BMC Med Genomics        ISSN: 1755-8794            Impact factor:   3.063


  32 in total

Review 1.  Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women.

Authors:  J M Bowen; L Chamley; M D Mitchell; J A Keelan
Journal:  Placenta       Date:  2002-04       Impact factor: 3.481

2.  The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia.

Authors:  Dorota Darmochwal-Kolarz; Magdalena Kludka-Sternik; Jacek Tabarkiewicz; Bogdan Kolarz; Jacek Rolinski; Bozena Leszczynska-Gorzelak; Jan Oleszczuk
Journal:  J Reprod Immunol       Date:  2012-02-25       Impact factor: 4.054

3.  Is ethnicity a risk factor for developing preeclampsia? An analysis of the prevalence of preeclampsia in China.

Authors:  J Xiao; F Shen; Q Xue; G Chen; K Zeng; P Stone; M Zhao; Q Chen
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

4.  New data about preeclampsia: some possibilities of prevention.

Authors:  Adolf E Schindler
Journal:  Gynecol Endocrinol       Date:  2018-03-06       Impact factor: 2.260

5.  IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy.

Authors:  Pushpinder Dhillion; Kedra Wallace; Florian Herse; Jeremy Scott; Gerd Wallukat; Judith Heath; Janae Mosely; James N Martin; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-06-20       Impact factor: 3.619

6.  A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour.

Authors:  Mika Ito; Akitoshi Nakashima; Takao Hidaka; Motonori Okabe; Nguyen Duy Bac; Shihomi Ina; Satoshi Yoneda; Arihiro Shiozaki; Shigeki Sumi; Koichi Tsuneyama; Toshio Nikaido; Shigeru Saito
Journal:  J Reprod Immunol       Date:  2009-12-06       Impact factor: 4.054

7.  Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy.

Authors:  Denise C Cornelius; James P Hogg; Jeremy Scott; Kedra Wallace; Florian Herse; Janae Moseley; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Hypertension       Date:  2013-09-23       Impact factor: 10.190

8.  Hypertensive disorders and severe obstetric morbidity in the United States.

Authors:  Elena V Kuklina; Carma Ayala; William M Callaghan
Journal:  Obstet Gynecol       Date:  2009-06       Impact factor: 7.661

9.  The Role of Interleukin-17, Interleukin-23, and Transforming Growth Factor-β in Pregnancy Complicated by Placental Insufficiency.

Authors:  Dorota Darmochwal-Kolarz; Magdalena Michalak; Bogdan Kolarz; Monika Przegalinska-Kalamucka; Agnieszka Bojarska-Junak; Dariusz Sliwa; Jan Oleszczuk
Journal:  Biomed Res Int       Date:  2017-06-15       Impact factor: 3.411

10.  Role of IL-17 Variants in Preeclampsia in Chinese Han Women.

Authors:  Haiyan Wang; Mingzhen Guo; Fenghua Liu; Jingli Wang; Zheng Zhou; Jing Ji; Yuanhua Ye; Weiqing Song; Shiguo Liu; Bo Sun
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

View more
  2 in total

Review 1.  Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review

Authors:  Fajar Dwi Astarini; Neneng Ratnasari; Widya Wasityastuti
Journal:  Iran Biomed J       Date:  2022-07-01

Review 2.  Cytokine-polymorphisms associated with Preeclampsia: A review.

Authors:  Carlos Mora-Palazuelos; Mercedes Bermúdez; Maribel Aguilar-Medina; Rosalío Ramos-Payan; Alfredo Ayala-Ham; Jose Geovanni Romero-Quintana
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.